Aspire Biopharma Holdings, Inc.
ASBP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Market Cap | $94,891 | $528,741 | $528,741 |
| - Cash | $4 | $11 | $0 |
| + Debt | $1,267 | $361 | $28 |
| Enterprise Value | $96,154 | $529,090 | $528,769 |
| Revenue | $0 | $0 | $0 |
| % Growth | – | – | – |
| Gross Profit | $0 | $0 | $0 |
| % Margin | – | – | – |
| EBITDA | -$11,646 | -$359 | -$596 |
| % Margin | – | – | – |
| Net Income | -$12,537 | -$359 | -$597 |
| % Margin | – | – | – |
| EPS Diluted | -0.26 | -0.008 | -0.013 |
| % Growth | -3,233.3% | 40% | – |
| Operating Cash Flow | -$2,055 | -$653 | -$143 |
| Capital Expenditures | $0 | -$0 | -$4,895 |
| Free Cash Flow | -$2,055 | -$653 | -$5,038 |